The in vivo findings from our CAM model and intraperitoneal xenograft mouse model were consistent with our in vitro observations demonstrating annexin A2 promotes ovarian cancer cell motility, invasion and tumor growth. Here, ANXA2 is linked to ovarian carcinoma.